These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3101176)

  • 1. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses.
    Hannun YA; Bell RM
    Science; 1987 Feb; 235(4789):670-4. PubMed ID: 3101176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of protein kinase C by sphingosine and lysosphingolipids.
    Hannun YA; Bell RM
    Clin Chim Acta; 1989 Dec; 185(3):333-45. PubMed ID: 2695275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis of Neuro2a cells induced by lysosphingolipids with naturally occurring stereochemical configurations.
    Sueyoshi N; Maehara T; Ito M
    J Lipid Res; 2001 Aug; 42(8):1197-202. PubMed ID: 11483620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets.
    Hannun YA; Loomis CR; Merrill AH; Bell RM
    J Biol Chem; 1986 Sep; 261(27):12604-9. PubMed ID: 3462188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of synthetic sphingosine, lysosphingolipids and glycosphingolipids as inhibitors of functional responses of human neutrophils.
    Fiore S; Nicolaou KC; Caulfield T; Kataoka H; Serhan CN
    Biochem J; 1990 Feb; 266(1):25-31. PubMed ID: 2155608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytochrome c oxidase and hemolysis caused by lysosphingolipids.
    Igisu H; Hamasaki N; Ito A; Ou W
    Lipids; 1988 Apr; 23(4):345-8. PubMed ID: 2840545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer.
    Dubot P; Astudillo L; Therville N; Carrié L; Pettazzoni M; Cheillan D; Stirnemann J; Levade T; Andrieu-Abadie N; Sabourdy F
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosylphosphorylcholine and lysosulfatide have inverse regulatory functions in monocytic cell differentiation into macrophages.
    Yamamoto H; Naito Y; Okano M; Kanazawa T; Takematsu H; Kozutsumi Y
    Arch Biochem Biophys; 2011 Feb; 506(1):83-91. PubMed ID: 21081108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux.
    Nofer JR; Fobker M; Höbbel G; Voss R; Wolinska I; Tepel M; Zidek W; Junker R; Seedorf U; von Eckardstein A; Assmann G; Walter M
    Biochemistry; 2000 Dec; 39(49):15199-207. PubMed ID: 11106499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease.
    Spassieva S; Bieberich E
    J Neurosci Res; 2016 Nov; 94(11):974-81. PubMed ID: 27638582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C regulation by sphingosine/lysosphingolipids.
    Bell RM; Loomis CR; Hannun YA
    Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 1():103-10. PubMed ID: 3076075
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of phosphoinositide hydrolysis in cultured astrocytes by sphingosine and psychosine.
    Ritchie T; Rosenberg A; Noble EP
    Biochem Biophys Res Commun; 1992 Jul; 186(2):790-5. PubMed ID: 1323292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond a structural component: sphingolipids in immunology.
    Prieschl EE; Baumruker T
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):163-71. PubMed ID: 10912620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease.
    Pettazzoni M; Froissart R; Pagan C; Vanier MT; Ruet S; Latour P; Guffon N; Fouilhoux A; Germain DP; Levade T; Vianey-Saban C; Piraud M; Cheillan D
    PLoS One; 2017; 12(7):e0181700. PubMed ID: 28749998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sphingosine and other sphingolipids on protein kinase C.
    Smith ER; Merrill AH; Obeid LM; Hannun YA
    Methods Enzymol; 2000; 312():361-73. PubMed ID: 11070884
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of calcium-activated, phospholipid-dependent protein kinase (protein kinase C) activity in sphingolipidoses.
    Boneh A
    J Inherit Metab Dis; 1991; 14(3):393-6. PubMed ID: 1770800
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of phosphorylase kinase activity by sphingolipids.
    Baltas LG; Zevgolis VG; Kyriakidis SM; Sotiroudis TG; Evangelopoulos AE
    Biochem Int; 1989 Jul; 19(1):99-106. PubMed ID: 2775303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation.
    Hannun YA; Bell RM
    Science; 1989 Jan; 243(4890):500-7. PubMed ID: 2643164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of D-erythro-sphingosine as a pharmacological inhibitor of protein kinase C in human platelets.
    Khan WA; Mascarella SW; Lewin AH; Wyrick CD; Carroll FI; Hannun YA
    Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):387-92. PubMed ID: 1898331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingolipids inhibit multistage carcinogenesis and protein kinase C.
    Borek C; Merrill AH
    Basic Life Sci; 1993; 61():367-71. PubMed ID: 8304947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.